Cite
Impaired apoptosis underlying lymphoproliferative disease in a patient with haploinsufficient NFKB1 deficiency.
MLA
Roussel, Lucie, et al. “Impaired Apoptosis Underlying Lymphoproliferative Disease in a Patient with Haploinsufficient NFKB1 Deficiency.” British Journal of Haematology, vol. 205, no. 5, Nov. 2024, pp. 2089–93. EBSCOhost, https://doi.org/10.1111/bjh.19814.
APA
Roussel, L., Bernier, S., Perez, A., Sun, Y., Angers, I., Laneuville, P., Lawandi, A., & Vinh, D. C. (2024). Impaired apoptosis underlying lymphoproliferative disease in a patient with haploinsufficient NFKB1 deficiency. British Journal of Haematology, 205(5), 2089–2093. https://doi.org/10.1111/bjh.19814
Chicago
Roussel, Lucie, Stephane Bernier, Anna Perez, Yichun Sun, Isabelle Angers, Pierre Laneuville, Alexander Lawandi, and Donald C. Vinh. 2024. “Impaired Apoptosis Underlying Lymphoproliferative Disease in a Patient with Haploinsufficient NFKB1 Deficiency.” British Journal of Haematology 205 (5): 2089–93. doi:10.1111/bjh.19814.